• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Ironwood Pharmaceuticals, Inc. (IRWD)

    -NasdaqGS
    15.58 Down 0.46(2.87%) Jan 30, 4:00PM EST
    |After Hours : 15.58 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:16.04
    Open:15.94
    Bid:N/A
    Ask:29.99 x 100
    1y Target Est:14.04
    Beta:1.51
    Next Earnings Date:12-Feb-15IRWD Earnings announcement
    Day's Range:15.57 - 16.39
    52wk Range:9.01 - 17.11
    Volume:868,071
    Avg Vol (3m):864,294
    Market Cap:2.18B
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IRWDDown 2.87%2.18B
    SHPGDown 1.31%42.95B
    SCMPDown 5.64%659.70M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):51.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.32
    Quarterly EPS Est (Dec-14) :-0.21
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-0.62

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company’s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback